Noriaki Nakai Selected Research

Noriaki Nakai Research Topics

Disease

9	Drug Eruptions (Drug Eruption) 05/2016 - 12/2011
8	Melanoma (Melanoma, Malignant) 12/2012 - 07/2006
6	Neoplasms (Cancer) 04/2015 - 07/2006
3	Hypersensitivity (Allergy) 10/2010 - 07/2006
2	Erythema Multiforme 12/2012 - 12/2011
1	Cognitive Dysfunction 04/2015
1	Residual Neoplasm 04/2015
1	Acute Generalized Exanthematous Pustulosis 03/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2015
1	Common Cold 03/2015
1	Cough 03/2015
1	Mycosis Fungoides 01/2014
1	Rheumatoid Arthritis 01/2014
1	Angiolymphoid Hyperplasia with Eosinophilia 01/2014
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2014
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2014
1	Localized Scleroderma (Morphea) 09/2013
1	Allergic Contact Dermatitis 04/2013
1	Neoplasm Metastasis (Metastasis) 12/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2012
1	Fibroma (Fibromatosis) 01/2012
1	Basal Cell Carcinoma (Rodent Ulcer) 04/2010
1	Experimental Melanoma 04/2010
1	Blister (Bulla) 09/2008
1	Ulcer 09/2008
1	Sepsis (Septicemia) 09/2008

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 04/2009 - 12/2008
2	TabletsIBA 12/2013 - 01/2013
2	Fluconazole (Zonal)FDA LinkGeneric 03/2013 - 01/2013
2	Peptides (Polypeptides)IBA 01/2009 - 07/2006
1	Promethazine (Promet)FDA LinkGeneric 05/2016
1	loxoprofen (CS 600)IBA 10/2015
1	SodiumIBA 10/2015
1	zinc chloride FDA Link 04/2015
1	dihydrocodeine FDA LinkGeneric 03/2015
1	tulobuterolIBA 03/2015
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 03/2015
1	Clarithromycin (Biaxin)FDA LinkGeneric 03/2015
1	Amoxicillin (Wymox)FDA LinkGeneric 03/2015
1	Phosphates (Orthophosphate)IBA 03/2015
1	tipepidineIBA 03/2015
1	Sitagliptin Phosphate (Januvia)FDA Link 09/2014
1	Imiquimod (Aldara)FDA LinkGeneric 01/2014
1	methyl 4-formylphenyl phosphateIBA 01/2014
1	Methotrexate (Mexate)FDA LinkGeneric 01/2014
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2013
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 04/2013
1	cytidylyl-3'-5'-guanosineIBA 12/2012
1	Interferon-betaIBA 12/2012
1	Lamotrigine (Lamictal)FDA LinkGeneric 12/2012
1	Dacarbazine (DIC)FDA LinkGeneric 12/2012
1	OligodeoxyribonucleotidesIBA 12/2012
1	PotassiumIBA 11/2012
1	tegafur-gimeracil-oteracilIBA 11/2012
1	Keratins (Keratin)IBA 01/2012
1	VimentinIBA 01/2012
1	DesminIBA 01/2012
1	Alcian BlueIBA 01/2012
1	Syntex adjuvant formulationIBA 01/2012
1	Celecoxib (Celebrex)FDA Link 12/2011
1	InterferonsIBA 10/2010
1	VaccinesIBA 10/2010
1	Interleukin-12 (IL 12)IBA 04/2010
1	DNA (Deoxyribonucleic Acid)IBA 04/2010
1	Melanins (Melanin)IBA 04/2010
1	CytokinesIBA 04/2010
1	Small Interfering RNA (siRNA)IBA 04/2010
1	Microphthalmia-Associated Transcription FactorIBA 04/2010
1	Messenger RNA (mRNA)IBA 04/2009
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2008
1	CollagenIBA 09/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2008
1	ImmunosorbentsIBA 07/2006
1	EnzymesIBA 07/2006

Therapy/Procedure

4	Therapeutics 12/2012 - 07/2006
2	Radiotherapy 04/2015 - 01/2014
1	Palliative Care (Palliative Therapy) 04/2015
1	Debridement 04/2015
1	Lymph Node Excision (Lymph Node Dissection) 05/2010
1	Neoadjuvant Therapy 05/2010
1	Cryotherapy (Therapy, Cold) 04/2010
1	Immunotherapy 07/2006